Characteristics of hematopoietic stem cell transplantation patients and donors
. | HSCT donor → patient sex . | . | . | . | |||
|---|---|---|---|---|---|---|---|
. | F → M n = 60 . | M → M n = 39 . | F → F n = 28 . | M → F n = 23 . | |||
| Patient age, y | |||||||
| Median | 47 | 48 | 44 | 42 | |||
| Range | 19-66 | 21-62 | 22-60 | 22-58 | |||
| Donor age, y | |||||||
| Median | 42 | 36 | 39 | 38 | |||
| Range | 2-70 | 21-64 | 22-59 | 16-63 | |||
| Donor relation, no. (%) | |||||||
| Unrelated | 15 (25) | 18 (46) | 16 (57) | 8 (35) | |||
| Related | 45 (75) | 21 (54) | 12 (43) | 15 (65) | |||
| HSC source, no. (%) | |||||||
| Bone marrow | 46 (77) | 23 (59) | 21 (75) | 18 (78) | |||
| PBSCs | 14 (23) | 16 (41) | 7 (25) | 5 (22) | |||
| HSC processing, no. (%) | |||||||
| Unmanipulated | 37 (62) | 25 (64) | 24 (86) | 19 (83) | |||
| T-cell depleted | 23 (38) | 14 (36) | 4 (14) | 4 (17) | |||
| Conditioning regimen, no. (%) | |||||||
| Myeloablative | 48 (80) | 27 (69) | 22 (78.6) | 20 (87) | |||
| Nonmyeloablative | 12 (20) | 12 (31) | 6 (21.4) | 3 (13) | |||
. | HSCT donor → patient sex . | . | . | . | |||
|---|---|---|---|---|---|---|---|
. | F → M n = 60 . | M → M n = 39 . | F → F n = 28 . | M → F n = 23 . | |||
| Patient age, y | |||||||
| Median | 47 | 48 | 44 | 42 | |||
| Range | 19-66 | 21-62 | 22-60 | 22-58 | |||
| Donor age, y | |||||||
| Median | 42 | 36 | 39 | 38 | |||
| Range | 2-70 | 21-64 | 22-59 | 16-63 | |||
| Donor relation, no. (%) | |||||||
| Unrelated | 15 (25) | 18 (46) | 16 (57) | 8 (35) | |||
| Related | 45 (75) | 21 (54) | 12 (43) | 15 (65) | |||
| HSC source, no. (%) | |||||||
| Bone marrow | 46 (77) | 23 (59) | 21 (75) | 18 (78) | |||
| PBSCs | 14 (23) | 16 (41) | 7 (25) | 5 (22) | |||
| HSC processing, no. (%) | |||||||
| Unmanipulated | 37 (62) | 25 (64) | 24 (86) | 19 (83) | |||
| T-cell depleted | 23 (38) | 14 (36) | 4 (14) | 4 (17) | |||
| Conditioning regimen, no. (%) | |||||||
| Myeloablative | 48 (80) | 27 (69) | 22 (78.6) | 20 (87) | |||
| Nonmyeloablative | 12 (20) | 12 (31) | 6 (21.4) | 3 (13) | |||
PBSCs indicates peripheral blood stem cells.